ADVANCEMENTS IN RECOMBINANT HUMAN SERUM ALBUMIN FOR BIOPHARMACEUTICAL APPS

Recombinant human serum albumin (OsrHSA) has emerged as a major innovation in the sector of biopharmaceuticals, offering promising progress across a variety of health care and industrial applications. With its structural similarity to In a natural way derived human serum albumin, OsrHSA offers a safer, additional trusted alternative for therapeutic